'Coping with Cancer from the Outside In' Program to Launch at the Annual Oncology Nursing Society Congress
THOUSAND OAKS, Calif., April 30 /PRNewswire-FirstCall/ -- Amgen and ONSEdge, a subsidiary of the Oncology Nursing Society (ONS), today announced that they will partner alongside celebrity make-up artist and cancer survivor Jan Ping to support a new educational campaign, Coping with Cancer From the Outside In. The initiative is aimed at educating oncology nurses about the skin-related side effects associated with epidermal growth factor receptor (EGFR) inhibitors that are used to treat metastatic colorectal, lung, pancreatic, and head and neck cancers.
EGFR inhibitor therapy aims to interrupt tumor growth by disrupting signals sent from the epidermal growth factor receptor, which is found on the surface of some cancer cells. Because EGFR is also present on other normal cells in the body, including skin cells, skin rash occurs in up to 90 percent of patients undergoing treatment with an EGFR inhibitor. This can be serious and potentially life threatening. Further, in its mild-to-moderate state, skin rash can cause patients physical discomfort and take an emotional toll, affecting body image. For most patients these side effects are mild, but moderate or severe toxicities that lead to dose modification or interruption develop in 8-17 percent of patients. Other appearance-related side effects include nail changes, skin cracking and hair disorders.
"Oncology nurses serve as a patient's advocate and help them manage the side effects of cancer therapy," said Beth A. Zubal, RN, oncology nurse practitioner at the
The campaign will kick off at the Annual ONS Congress on April 30, 2009 in San Antonio, Texas, where leading oncology experts an
Copyright©2009 PR Newswire.
All rights reserved